Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on May 27, 2025
Neuphoria to Present at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual Meeting
GlobeNewswire
·
May 27, 2025
BURLINGTON, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (“Neuphoria” or the “Company”), a clinical-stage biotechnology company developing impactful treatments for neuropsychiatric disorders, today announced an …
Assembly Biosciences to Present During the Jefferies 2025 Global Healthcare Conference
GlobeNewswire
·
May 27, 2025
SOUTH SAN FRANCISCO, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced that Jason Okazaki, chief executive …
Myriad Genetics Highlights New Research Advancements and Oncology Innovations at 2025 ASCO Annual Meeting
GlobeNewswire
·
May 27, 2025
SALT LAKE CITY, May 27, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced it will share data from seven new research studies at the 2025 ASCO Annual Meeting, including …
PetMed Express, Inc. Sets Fourth Quarter and Full Fiscal Year 2025 Earnings Call
GlobeNewswire
·
May 27, 2025
DELRAY BEACH, Fla., May 27, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) will hold a conference call on Tuesday, June 10, 2025 at 4:30pm Eastern Time to discuss its financial results for the …
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
GlobeNewswire
·
May 27, 2025
Company announcement – No. 13 / 2025 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, May 27, 2025 – Zealand Pharma A/S ("the …
Inventiva to Participate in the Upcoming Jefferies Global Healthcare Conference and UBS Spring Biotech Conference
GlobeNewswire
·
May 27, 2025
Daix (France), New York City (New York, United States), May 27, 2025 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of …
Inventiva Participera à la « Jefferies Global Healthcare Conference » et à la « UBS Spring Biotech Conference »
GlobeNewswire
·
May 27, 2025
Daix (France), New York City (New York, Etats-Unis), le 27 mai 2025 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de thérapies orales pour le traitement de la …
Dr. Jeremy Saul Announces National Scholarship Initiative to Support Aspiring Medical Students Pursuing Careers in Healthcare
GlobeNewswire
·
May 27, 2025
RUSSELLVILLE, Ark., May 27, 2025 (GLOBE NEWSWIRE) -- The Dr. Jeremy Saul Scholarship for Medical Students is now officially open for applications, offering aspiring undergraduate students across the United States the opportunity to receive a one-time award …
Dr. David Webb Launches National Scholarship Initiative to Support Aspiring Healthcare Professionals with a Vision to Serve
GlobeNewswire
·
May 27, 2025
PACATELLO, Idaho, May 27, 2025 (GLOBE NEWSWIRE) -- The Dr. David Webb Scholarship for Future Doctors is now accepting applications from students across the United States who are dedicated to building careers in healthcare. Spearheaded by Dr. David Webb, …
Scientific Industries to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
GlobeNewswire
·
May 27, 2025
BOHEMIA, N.Y., May 27, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced it will participate in a webcast presentation and host one- …
Leading Independent Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote “FOR” All of Keros’ Director Nominees
GlobeNewswire
·
May 27, 2025
Keros Board Best Equipped to Oversee Strategic Review Process and Execute on Ultimate Outcome of that Process ADAR1’s Disruptive and Self-Serving Campaign Stands to Jeopardize the Future Value Maximizing Potential of the Company Keros Urges Stockholders to …
Global Experts from 23 Countries Convene in Barcelona to Confront Rising Rates of Early Onset Colorectal Cancer
GlobeNewswire
·
May 27, 2025
Springfield, Mo., May 27, 2025 (GLOBE NEWSWIRE) -- Fight Colorectal Cancer (Fight CRC), in partnership with Dr. José Perea of the Instituto de Investigación Biomédica de Salamanca (IBSAL) and a global network of collaborators, will host the inaugural …
Pattern Computer Announces Hepatocellular Carcinoma Pattern Identification and Model Creation Study
GlobeNewswire
·
May 27, 2025
Study leveraged Pattern Discovery Engine™ to construct highly accurate model to predict whether or not a given cell is cancerous Identified nine genes that are crucial for prediction and may have other uses in diagnostics and/or therapeutics Highlights use …
Liposarcoma Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 15+ Companies and 20+ Therapies | DelveInsight
GlobeNewswire
·
May 27, 2025
New York, USA, May 27, 2025 (GLOBE NEWSWIRE) -- Liposarcoma Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 15+ Companies and 20+ Therapies | DelveInsight The liposarcoma treatment market is driven by a rising global disease burden and …
23andMe Announces Intent to Voluntarily Delist from Nasdaq and Deregister with the SEC
GlobeNewswire
·
May 27, 2025
SAN FRANCISCO, May 27, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (OTC: MEHCQ), a leading human genetics and biotechnology company, today announced its intention to file a Form 25 Notification of Delisting with the Securities …
CARBIOS unterzeichnet erste Verträge über den Verkauf von biologisch recyceltem PET mit zwei weltweit führenden Kosmetikunternehmen
GlobeNewswire
·
May 27, 2025
CARBIOS hat zwei mehrjährige Verträge mit L'ORÉAL und L'Occitane en Provence über den Verkauf von enzymatisch recyceltem und recycelbarem PET aus seiner Anlage in Longlaville unterzeichnet und hat die Umsetzung seiner Strategie für die künftige Anlage …
CARBIOS signs its first biorecycled PET sales contracts with two global cosmetics leaders
GlobeNewswire
·
May 27, 2025
CARBIOS has signed two multi-year commercial contracts for biorecycled PET from its Longlaville plant, with L'ORÉAL and L'Occitane en Provence, and has moved forward with the execution of this future plant’s strategy These initial commercial contracts …
CARBIOS signe ses premiers contrats de vente de PET biorecyclé avec deux leaders mondiaux de la cosmétique
GlobeNewswire
·
May 27, 2025
CARBIOS a signé deux contrats commerciaux pluriannuels de PET biorecyclé issu de l’usine de Longlaville, avec L’ORÉAL et L’Occitane en Provence et réalise une avancée dans l’exécution de sa stratégie pour sa future usine de Longlaville Ces premiers …
Avalo Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 27, 2025
WAYNE, Pa. and ROCKVILLE, Md., May 27, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused on the treatment of immune dysregulation, today announced that management will participate in the …
Clinical asset management industry report highlights major trends reshaping health care in 2025
GlobeNewswire
·
May 27, 2025
Indianapolis, Indiana, May 27, 2025 (GLOBE NEWSWIRE) -- As health care enters a new era marked by technological innovation and regulatory challenges, TRIMEDX has released a 2025 industry report on clinical asset management, offering a deep dive into the …